Stocks rise as AstraZeneca resumes vaccine trial - Yahoo Finance

Stocks rose worldwide on Monday as AstraZeneca (AZN.L) and Oxford University confirmed plans to resume a leading coronavirus vaccine trial.

In large trials such as this, it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety,” said the university in a statement.

“European stocks have got off to a positive start to the week helped by a decent performance in Asia, as well as renewed optimism over progress on a possible vaccine after AstraZeneca resumed its UK trials after last week’s suspension over safety concerns, and possible side effects," said Michael Hewson, chief market analyst at CMC Markets UK.

S&P 500 futures (ES=F) were trading 1.4% higher, Dow Jones futures (YM=F) rose 1.2%, and Nasdaq futures (NQ=F) leapt 1.8%.